When the generic drug market is often synonym of blockbuster race and cost cutting, STRAGEN has always been engaged in the development of Selected and Advanced Generics.

Thanks to our 30-year R&D know-how, we constantly aim at improving the existing therapeutics by offering: Niche molecules, Hard-to-make drugs and Innovative delivery forms to improve health daily practices.